Literature DB >> 1438291

Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.

W Ruan1, C B Newman, D L Kleinberg.   

Abstract

Growth hormone (GH) plays a role in regulating growth and differentiation of immature glandular structures in the mammary gland, but the mechanisms by which the hormone exerts these effects are unknown. We have previously found that GH stimulates insulin-like growth factor I (IGF-I) I mRNA production within the mammary glands of hypophysectomized rats. In this study we set out to determine if IGF-I administration could mimic the action of GH in initiating mammary gland differentiation and development. Two forms of IGF-I, intact and amino-terminally shortened [des-(1-3)-IGF-I], were found to induce the development of terminal end buds and the formation of alveolar structures in the mammary glands of hypophysectomized, castrated, and estradiol-treated sexually immature male rats. The effect of both forms of IGF-I was similar to that obtained with human GH, but the truncated form was at least 5 times more potent than intact IGF-I. These findings suggest that the inductive effect of GH on glandular differentiation is mediated by the GH-induced production of IGF-I or a related molecule within the mammary gland itself.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438291      PMCID: PMC50444          DOI: 10.1073/pnas.89.22.10872

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse.

Authors:  S NANDI
Journal:  J Natl Cancer Inst       Date:  1958-12       Impact factor: 13.506

Review 2.  Growth factors in mammary gland function.

Authors:  I A Forsyth
Journal:  J Reprod Fertil       Date:  1989-03

3.  Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation.

Authors:  G A Jahn; M Edery; L Belair; P A Kelly; J Djiane
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

4.  A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1).

Authors:  C Carlsson-Skwirut; M Lake; M Hartmanis; K Hall; V R Sara
Journal:  Biochim Biophys Acta       Date:  1989-05-10

Review 5.  Control of human breast cancer by estrogen, growth factors, and oncogenes.

Authors:  R B Dickson; M E Lippman
Journal:  Cancer Treat Res       Date:  1988

6.  An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture.

Authors:  Q T Rohlik; D Adams; F C Kull; S Jacobs
Journal:  Biochem Biophys Res Commun       Date:  1987-11-30       Impact factor: 3.575

7.  Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Authors:  C L Arteaga; L J Kitten; E B Coronado; S Jacobs; F C Kull; D C Allred; C K Osborne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

8.  Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland.

Authors:  D L Kleinberg; W Ruan; V Catanese; C B Newman; M Feldman
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

9.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

Authors:  D Yee; S Paik; G S Lebovic; R R Marcus; R E Favoni; K J Cullen; M E Lippman; N Rosen
Journal:  Mol Endocrinol       Date:  1989-03

10.  Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

Authors:  E M Berns; J G Klijn; I L van Staveren; H Portengen; J A Foekens
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

View more
  24 in total

Review 1.  IGF and insulin action in the mammary gland: lessons from transgenic and knockout models.

Authors:  D L Hadsell; S G Bonnette
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

Review 2.  Programmed cell death in the terminal endbud.

Authors:  R C Humphreys
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 3.  Animal models for the study of milk secretion.

Authors:  C J Wilde; W L Hurley
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

4.  Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.

Authors:  Stephanie R Thorn; Sarah L Giesy; Martin G Myers; Yves R Boisclair
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

5.  Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.

Authors:  David L Kleinberg; Pietro Ameri; Baljit Singh
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

6.  Canonical pathways and networks regulated by estrogen in the bovine mammary gland.

Authors:  Robert W Li; Anthony V Capuco
Journal:  Funct Integr Genomics       Date:  2007-08-01       Impact factor: 3.410

Review 7.  The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands.

Authors:  T L Wood; M M Richert; M A Stull; M A Allar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

Review 8.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

9.  Editorial: The mammary stroma in normal development and function.

Authors:  Pepper Schedin; Russell C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-09       Impact factor: 2.673

Review 10.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.